These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 30408650)
1. Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain. Li W; Yin Y; Shuai W; Xu F; Yao H; Liu J; Cheng K; Xu J; Zhu Z; Xu S Bioorg Chem; 2019 Mar; 83():380-390. PubMed ID: 30408650 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site. Li W; Sun H; Xu F; Shuai W; Liu J; Xu S; Yao H; Ma C; Zhu Z; Xu J Bioorg Chem; 2019 Apr; 85():49-59. PubMed ID: 30599412 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors. Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site. Shao YY; Yin Y; Lian BP; Leng JF; Xia YZ; Kong LY Eur J Med Chem; 2020 Mar; 190():112105. PubMed ID: 32035399 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site. Hu X; Li L; Zhang Q; Wang Q; Feng Z; Xu Y; Xia Y; Yu L Bioorg Chem; 2020 Apr; 97():103695. PubMed ID: 32120073 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of quinoxaline derivatives as tubulin polymerization inhibitors that elevate intracellular ROS and triggers apoptosis via mitochondrial pathway. Qi J; Huang J; Zhou X; Luo W; Xie J; Niu L; Yan Z; Luo Y; Men Y; Chen Y; Zhang Y; Wang J Chem Biol Drug Des; 2019 Apr; 93(4):617-627. PubMed ID: 30635972 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors. Shuai W; Li X; Li W; Xu F; Lu L; Yao H; Yang L; Zhu H; Xu S; Zhu Z; Xu J Eur J Med Chem; 2020 Jul; 197():112308. PubMed ID: 32339853 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors. Donthiboina K; Anchi P; Gurram S; Sai Mani G; Lakshmi Uppu J; Godugu C; Shankaraiah N; Kamal A Bioorg Chem; 2020 Oct; 103():104191. PubMed ID: 32891862 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site. Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of new 2-oxoquinoline arylaminothiazole derivatives as potential anticancer agents. Fang Y; Wu Z; Xiao M; Wei L; Li K; Tang Y; Ye J; Xiang J; Hu A Bioorg Chem; 2021 Jan; 106():104469. PubMed ID: 33239239 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization. Zhang R; Mo H; Ma YY; Zhao DG; Zhang K; Zhang T; Chen X; Zheng X Bioorg Med Chem Lett; 2021 May; 40():127968. PubMed ID: 33753264 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents. Prasad B; Lakshma Nayak V; Srikanth PS; Baig MF; Subba Reddy NV; Babu KS; Kamal A Bioorg Chem; 2019 Mar; 83():535-548. PubMed ID: 30472555 [TBL] [Abstract][Full Text] [Related]
13. SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell Lines. Yan W; Yang T; Yang J; Wang T; Yu Y; Wang Y; Chen Q; Bai P; Li D; Ye H; Qiu Q; Zhou Y; Hu Y; Yang S; Wei Y; Li W; Chen L Cell Physiol Biochem; 2018; 47(2):489-504. PubMed ID: 29794416 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of imidazo-thiadiazole linked indolinone conjugates and evaluated their microtubule network disrupting and apoptosis inducing ability. Narasimha Rao MP; Nagaraju B; Kovvuri J; Polepalli S; Alavala S; Vishnuvardhan MVPS; Swapna P; Nimbarte VD; Lakshmi JK; Jain N; Kamal A Bioorg Chem; 2018 Feb; 76():420-436. PubMed ID: 29275261 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities. Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors. Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors. Sana S; Tokala R; Bajaj DM; Nagesh N; Bokara KK; Kiranmai G; Lakshmi UJ; Vadlamani S; Talla V; Shankaraiah N Bioorg Chem; 2019 Dec; 93():103317. PubMed ID: 31586714 [TBL] [Abstract][Full Text] [Related]